openPR Logo
Press release

Dual Antiplatelet Therapy Market : Precise Scenario Covering Trends, Opportunities and Growth Forecast during 2018-2028 | Top growing Industries- Bayer AG, Novacap, Shiono Chemical Co., Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharm

11-14-2018 09:10 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Platelets are small blood particles that clump together to form clots. Sometimes, these clots may lead to myocardial infarction or a sudden blockage in the coronary artery. Antiplatelets are a class of drugs that inhibit blood clot formation. Many heart attack and stroke patients are treated with two types of antiplatelet drugs to prevent blood clotting. This is known as dual antiplatelet therapy. Dual antiplatelet therapy is a combination therapy which utilizes two antiplatelet drugs. One of the drugs in dual antiplatelet therapy is aspirin. Patients who have coronary artery disease, heart attack, coronary artery bypass surgery or stents are treated with aspirin for the rest of their life. The second drug in dual antiplatelet therapy is a P2Y12 inhibitor – either clopidogrel, pasugrel, or ticagrelor. Dual antiplatelet therapy leads to greater platelet inhibition than what is achieved by aspirin alone, thus, decreasing the likelihood of future blood clot formations in the coronary arteries and heart attacks.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1002

Dual Antiplatelet Therapy Market: Drivers and Restraints

The growing prevalence and recurrence of cardiac diseases is expected to be the major factor driving the growth of the dual antiplatelet therapy market over the forecast period. According to World Health Organization, cardiac disease is the number one cause of death globally. An estimated 17.2 million people die of cardiac diseases, representing 31% of global deaths, annually. Off the 17.2 million people, approximately 7.4 million people died due to coronary heart disease, whereas nearly 6.7 million died due to stroke. Changes in lifestyle and eating habits are attributed to the growing prevalence of cardiac diseases. Research & Development of antiplatelet therapies is another factor contributing to the growth of the global dual antiplatelet therapy market. However, costs associated and lack of awareness about dual antiplatelet therapy market are some of the factors restraining the growth of dual antiplatelet therapy market.

Dual Antiplatelet Therapy Market: Segmentation

Tentatively, the global dual antiplatelet therapy market can be segmented on the basis of product type, indication, distribution channel, and geography.

Based on product type, the global dual antiplatelet therapy market is segmented as:

Aspirin
Clopidogel
Prasugrel
Ticagrelor
Based on indications, the global dual antiplatelet therapy market is segmented as:

Myocardial Infarction
Stable Ischemic Heart Disease
Bare-metal stent (BMS)
Drug-Eluting Stent (DES)
Coronary Artery Bypass Graft Surgery (CABG)
Acute Coronary Syndromes
Fibrinolysis
Percutaneous Coronary Artery Intervention
Based on distribution channel, the global Dual Antiplatelet Therapy Market is segmented as:

Hospital Pharmacies
Independent Pharmacies
Retail Pharmacies
Online Pharmacy
Dual Antiplatelet Therapy Market: Overview

The global market for dual antiplatelet therapy is expected to witness moderate growth over the forecast period. There is a high competition among local and regional players as majority of the antibiotics are introduced in the generic market. Among the two treatment types, the antibiotic treatment segment is expected to lead in the global dual antiplatelet therapy market over the forecast period. Retail pharmacy distribution channel is expected to contribute high share in the global dual antiplatelet therapy market as it is the most accessible channel and majority of the patients are recommended for outpatient treatment.

To know more about the Dual Antiplatelet Therapy Market Trends, visit this link- https://www.factmr.com/report/1002/dual-antiplatelet-therapy-market

Dual Antiplatelet Therapy Market: Regional Outlook

Geographically, the global dual antiplatelet therapy market is segmented into viz. North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global dual antiplatelet therapy market owing to high prevalence of the disease. The dual antiplatelet therapy market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing prevalence of cardiac diseases. Europe is expected to have the second largest share in the global dual antiplatelet therapy market throughout the forecast period.

Dual Antiplatelet Therapy Market: Key Players

The global market for dual antiplatelet therapy is highly fragmented. Examples of some of the key players operating in the global dual antiplatelet therapy market are Bayer AG, Novacap, Shiono Chemical Co., Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Eli Lilly & Co. Ltd. and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Access Research Methodology Prepared By Experts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1002

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at- https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dual Antiplatelet Therapy Market : Precise Scenario Covering Trends, Opportunities and Growth Forecast during 2018-2028 | Top growing Industries- Bayer AG, Novacap, Shiono Chemical Co., Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharm here

News-ID: 1368317 • Views:

More Releases from Fact.MR

Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% CAGR | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives. Furthermore, it is anticipated
Chemical Pulp Market Predicted to Garner US$ 19.5 Billion by 2033, At CAGR 7.4% | Fact.MR
Chemical Pulp Market Predicted to Garner US$ 19.5 Billion by 2033, At CAGR 7.4% …
According to the most recent data from market research and competitive intelligence provider Fact.MR, the global chemical pulp market is projected to grow at a compound annual growth rate (CAGR) of 7.4% between 2023 and 2033, reaching US$ 19.5 billion by the end of 2033. Large tanks called digesters are used to combine chemicals and wood chips to create chemical pulp. Lignin, which helps hold cellulose fibers together without seriously harming
Hemodialysis Market to Grow at 4.5% CAGR, Crossing US$ 149.92 Billion by 2033 | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Hemodialysis Market to Grow at 4.5% CAGR, Crossing US$ 149.92 Billion by 2033 | …
The hemodialysis market is expected to reach US$ 149.92 billion by 2033, from its estimated US$ 96.54 billion in 2023, according to a recent industry analysis by Fact.MR, a supplier of competitive intelligence and market research. Dialysis is a process that removes waste products from the blood, like creatinine and urea, which are created when the kidneys don't work properly. For people with chronic renal disorders, dialysis is required. Hemodialysis is
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by the end of 2034
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films. For More Insights

All 5 Releases


More Releases for Dual

Myers | Trilogy Adds Dual Mill Pulverizer
Alliance, OH -- Myers | Trilogy Plastics, a Myers Industries, Inc. Company (NYSE: MYE), has added a Dual Mill Pulverizer for additional capacity. "The new dual mill pulverizer effectively doubles powder output for molding operations," said Daren Balderson, Director of Eastern Operations-Myers Rotational Molding Platform. The "One Myers" approach embraces a growth mindset and is building on a foundation of operational excellence. Myers | Trilogy added the dual mill pulverizer to meet
Are you living with Dual Diagnosis?
Mental health disorders and substance use disorders often coexist. More than half of those individuals who suffer substance abuse are likely to have at least one significant mental health condition. The co-existing disorders are known as “dual diagnosis.” 8 common mental disorders that exist with substance abuse disorders among dual diagnosis patients are – * Major Depression * PTSD or Post-Traumatic Stress Disorder * Bipolar Disorder * Obsessive Compulsive Disorder * Borderline Personality Disorder * Anxiety Disorder *
Global Dual Dispensing Technology Market
Increasing demand for compact and easy to carry products is increasing among the consumers. Consumers are looking for cost effective product with multiple options for its applications. This accounts among the few important drivers for this market. The dual dispensing technology market is driven by increase in demand for smart and innovative dispensing systems and equipment in developing countries such as India and China. Dual dispensing technology offers the
Eliot Dudik Opens Dual Exhibitions
Photographer Eliot Dudik | Still Lives | Broken Land Exhibition: May 6 – June 25, 2016 Free, Public Welcome Artist Talk: June 3, 5:30-6:30 Free, Public Welcome Reception June 3, 6:30-9:00 Free, Public Welcome Eliot Dudik Dual Photography Exhibitions | THE CENTER FOR FINE ART PHOTOGRAPHY The Center presents Eliot Dudik’s series Broken Land in the Gould Gallery and his corresponding series Still Lives in the North Gallery
Broken Land |
4ipnet’s releases Dual-radio, Dual-band Long Range Access Point/Bridge
Taipei City, Taiwan, November 7th , 2012 -- 4ipnet, the leading provider of networking total solutions for wireless and wired Connectivity, Management, Security, Mobility and Services, has newly launched OWL610 and OWL620, long range outdoor AP/Bridge. Both the OWL610 and OWL620 support AP and bridge mode, as well as a last mile solution for wireless connectivity (WISP). Tunnel-based AP management features 4ipnet Secure WLAN Controllers to secure AP management. Rugged
4ipnet “King of Hotspot” Campaign highlights Dual-radio Dual-band Wireless H …
Taipei City, Taiwan, October 16, 2012 -- 4ipnet, Inc., a leading wireless networking device provider for manageable, reliable, and secure wireless access, announced the release of HSG320 and HSG327, dual-radio Hotspot Gateway providing an all-in-one solution for servicing clients and performing AAA (Authentication, Authorization & Accounting) for indoor high density venues. One dual-radio, dual band Hotspot Gateway can serve twice the amount of concurrent clients, increasing connectivity without increasing the